These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 2687379

  • 1. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE, Grabstein KH, Okuno K, Schreiber RD, Greenberg PD.
    J Immunol; 1989 Dec 15; 143(12):4308-16. PubMed ID: 2687379
    [Abstract] [Full Text] [Related]

  • 2. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U, Krammer PH.
    Eur J Immunol; 1985 Jan 15; 15(1):18-24. PubMed ID: 3917924
    [Abstract] [Full Text] [Related]

  • 3. Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma.
    Lee JC, Rebar L, Young P, Ruscetti FW, Hanna N, Poste G.
    J Immunol; 1986 Feb 15; 136(4):1322-8. PubMed ID: 3003193
    [Abstract] [Full Text] [Related]

  • 4. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
    Sadlik JR, Hoyer M, Leyko MA, Horvat R, Parmely M, Whitacre C, Zwilling B, Rinehart JJ.
    Cancer Res; 1985 May 15; 45(5):1940-5. PubMed ID: 3921233
    [Abstract] [Full Text] [Related]

  • 5. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
    Le J, Prensky W, Yip YK, Chang Z, Hoffman T, Stevenson HC, Balazs I, Sadlik JR, Vilcek J.
    J Immunol; 1983 Dec 15; 131(6):2821-6. PubMed ID: 6417232
    [Abstract] [Full Text] [Related]

  • 6. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A, Glasebrook AL, Kanagawa O, Brunner KT.
    J Immunol; 1982 Aug 15; 129(2):550-6. PubMed ID: 7045227
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S, Weyers M, Gong JH, Sprenger H, Nain M, Gemsa D.
    J Immunol; 1988 Mar 01; 140(5):1511-8. PubMed ID: 3126228
    [Abstract] [Full Text] [Related]

  • 8. Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line.
    Kleinerman ES, Zicht R, Sarin PS, Gallo RC, Fidler IJ.
    Cancer Res; 1984 Oct 01; 44(10):4470-5. PubMed ID: 6088039
    [Abstract] [Full Text] [Related]

  • 9. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
    Liew FY, Millott S, Li Y, Lelchuk R, Chan WL, Ziltener H.
    Eur J Immunol; 1989 Jul 01; 19(7):1227-32. PubMed ID: 2503386
    [Abstract] [Full Text] [Related]

  • 10. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T.
    J Immunol; 1985 Sep 01; 135(3):2199-205. PubMed ID: 3894520
    [Abstract] [Full Text] [Related]

  • 11. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D, Varesio L.
    J Immunol; 1981 Jul 01; 127(1):58-63. PubMed ID: 6787132
    [Abstract] [Full Text] [Related]

  • 12. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
    Taniyama T, Taki S, Akiyama Y, Yoshizawa K, Hamuro J, Arai K, Wong GG.
    Clin Invest Med; 1990 Dec 01; 13(6):305-12. PubMed ID: 2127737
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
    Biondi A, Roach JA, Schlossman SF, Todd RF.
    J Immunol; 1984 Jul 01; 133(1):281-5. PubMed ID: 6373929
    [Abstract] [Full Text] [Related]

  • 14. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    Kornbluth RS, Gregory SA, Edgington TS.
    J Immunol; 1988 Sep 15; 141(6):2006-15. PubMed ID: 3139748
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
    Kelso A, MacDonald HR, Smith KA, Cerottini JC, Brunner KT.
    J Immunol; 1984 Jun 15; 132(6):2932-8. PubMed ID: 6233365
    [Abstract] [Full Text] [Related]

  • 16. The induction and augmentation of macrophage tumoricidal responses by platelet-activating factor.
    Howard AD, Erickson KL.
    Cell Immunol; 1995 Aug 15; 164(1):105-12. PubMed ID: 7634340
    [Abstract] [Full Text] [Related]

  • 17. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
    Ratliff TL, Thomasson DL, McCool RE, Catalona WJ.
    J Reticuloendothel Soc; 1982 May 15; 31(5):393-7. PubMed ID: 6181257
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
    Kelso A, Glasebrook AL.
    J Immunol; 1984 Jun 15; 132(6):2924-31. PubMed ID: 6202766
    [Abstract] [Full Text] [Related]

  • 20. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
    Schreiber RD, Pace JL, Russell SW, Altman A, Katz DH.
    J Immunol; 1983 Aug 15; 131(2):826-32. PubMed ID: 6408190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.